Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Anti-VEGF antibody fragment safe, improves visual acuity in neovascular AMD

May 16, 2003

Combined use of two drug delivery systems after cataract surgery

May 16, 2003

Timolol-LA reported as effective as timolol maleate in reducing ocular hypertension

May 15, 2003

Dietary omega n-3 LCPUFAs reduce the risk for AMD

May 15, 2003

Genaera reports early findings for squalamine in AMD

May 14, 2003

Fab fragment targeting alpha5beta1 integrin inhibits CNV in monkeys

May 13, 2003

Antiviral and antiinflammatory effects for N-chlorotaurine in adenoviral keratoconjunctivitis

May 12, 2003

Once-monthly octreotide acetate improves visual acuity in cystoid macular edema

May 12, 2003

Timolol 0.1% gel as effective as latanoprost 0.005% gel in early glaucoma

May 9, 2003

Santen files NDA for levofloxacin 1.5%

May 9, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...